These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 36810441)

  • 21. Regulation and Effect of Telomerase and Telomeric Length in Stem Cells.
    Celtikci B; Erkmen GK; Dikmen ZG
    Curr Stem Cell Res Ther; 2021; 16(7):809-823. PubMed ID: 32321410
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low p16
    Graham MK; Principessa L; Antony L; Meeker AK; Isaacs JT
    Prostate; 2017 Mar; 77(4):374-384. PubMed ID: 27859428
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Senescence and immortalization: role of telomeres and telomerase.
    Shay JW; Wright WE
    Carcinogenesis; 2005 May; 26(5):867-74. PubMed ID: 15471900
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Telomere dynamics and homeostasis in a transmissible cancer.
    Ujvari B; Pearse AM; Taylor R; Pyecroft S; Flanagan C; Gombert S; Papenfuss AT; Madsen T; Belov K
    PLoS One; 2012; 7(8):e44085. PubMed ID: 22952882
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of oncogene expression on telomerase activation and telomere length in human endothelial, fibroblast and prostate epithelial cells.
    Burger AM; Fiebig HH; Kuettel MR; Lautenberger JA; Kung HF; Rhim JS
    Int J Oncol; 1998 Nov; 13(5):1043-8. PubMed ID: 9772298
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Telomere biology and immune system.
    Hathcock KS; Chiang YJ; Hodes RJ
    Discov Med; 2005 Jun; 5(27):288-92. PubMed ID: 20704890
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A two-stage, p16(INK4A)- and p53-dependent keratinocyte senescence mechanism that limits replicative potential independent of telomere status.
    Rheinwald JG; Hahn WC; Ramsey MR; Wu JY; Guo Z; Tsao H; De Luca M; Catricalà C; O'Toole KM
    Mol Cell Biol; 2002 Jul; 22(14):5157-72. PubMed ID: 12077343
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extension of cell life span using exogenous telomerase.
    Kang MK; Park NH
    Methods Mol Biol; 2007; 371():151-65. PubMed ID: 17634580
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Telomere and telomerase in stem cells.
    Hiyama E; Hiyama K
    Br J Cancer; 2007 Apr; 96(7):1020-4. PubMed ID: 17353922
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Telomere and telomerase in the initial stage of immortalization of esophageal epithelial cell.
    Shen ZY; Xu LY; Li EM; Cai WJ; Chen MH; Shen J; Zeng Y
    World J Gastroenterol; 2002 Apr; 8(2):357-62. PubMed ID: 11925625
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Telomerase and telomere: their structure and dynamics in health and disease].
    Mengual Gómez DL; Armando RG; Farina HG; Gómez DE
    Medicina (B Aires); 2014; 74(1):69-76. PubMed ID: 24561847
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A stochastic model of cell replicative senescence based on telomere shortening, oxidative stress, and somatic mutations in nuclear and mitochondrial DNA.
    Sozou PD; Kirkwood TB
    J Theor Biol; 2001 Dec; 213(4):573-86. PubMed ID: 11742526
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Telomeres, replicative senescence and human ageing.
    Kipling D
    Maturitas; 2001 Feb; 38(1):25-37; discussion 37-8. PubMed ID: 11311583
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alternative pathways for the extension of cellular life span: inactivation of p53/pRb and expression of telomerase.
    Vaziri H; Benchimol S
    Oncogene; 1999 Dec; 18(53):7676-80. PubMed ID: 10618707
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines.
    Bryan TM; Englezou A; Dalla-Pozza L; Dunham MA; Reddel RR
    Nat Med; 1997 Nov; 3(11):1271-4. PubMed ID: 9359704
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro aging of rat lung cells. Downregulation of telomerase activity and continuous decrease of telomere length are not incompatible with malignant transformation.
    Petitot F; Lebeau J; Dano L; Lectard B; Altmeyer S; Levalois C; Chevillard S
    Exp Cell Res; 2003 May; 286(1):30-9. PubMed ID: 12729792
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Telomerase activity in uveal melanomas].
    Rohrbach JM; Riedinger C; Wild M; Partsch M
    Ophthalmologe; 2000 May; 97(5):359-63. PubMed ID: 10892281
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A telomere-independent senescence mechanism is the sole barrier to Syrian hamster cell immortalization.
    Russo I; Silver AR; Cuthbert AP; Griffin DK; Trott DA; Newbold RF
    Oncogene; 1998 Dec; 17(26):3417-26. PubMed ID: 10030665
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Roles of Telomere Biology in Cell Senescence, Replicative and Chronological Ageing.
    Liu J; Wang L; Wang Z; Liu JP
    Cells; 2019 Jan; 8(1):. PubMed ID: 30650660
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells.
    Kiyono T; Foster SA; Koop JI; McDougall JK; Galloway DA; Klingelhutz AJ
    Nature; 1998 Nov; 396(6706):84-8. PubMed ID: 9817205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.